Pfizer’s CEO Albert Bourla and top management team held a planning meeting at Donald Trump’s Mar-a-Lago resort, seeking to build rapport with the president-elect. The move comes amid concerns over the appointment of vaccine skeptic Robert F Kennedy Jr to lead US health agencies. Bourla is among several corporate executives aiming to establish a direct relationship with Trump before his inauguration, with hopes of influencing policy on issues such as drug pricing and healthcare reform.
Full Article
Loading PerspectiveSplit analysis...
